MARKET

VNRX

VNRX

VOLITIONRX
AMEX

Real-time Quotes | Nasdaq Last Sale

4.760
+0.020
+0.42%
Closed 16:00 01/21 EST
OPEN
4.730
PREV CLOSE
4.740
HIGH
4.840
LOW
4.694
VOLUME
83.53K
TURNOVER
--
52 WEEK HIGH
6.84
52 WEEK LOW
2.110
MARKET CAP
193.13M
P/E (TTM)
-10.4630
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VNRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VNRX News

  • Volition Develops a New Improved Nu.Q Assay Format
  • PR Newswire.01/13 14:00
  • VolitionRx Completes Acquisition of Octamer GmbH
  • PR Newswire.01/10 13:00
  • How Many VolitionRx Limited (NYSEMKT:VNRX) Shares Did Insiders Buy, In The Last Year?
  • Simply Wall St..12/23/2019 19:30
  • VolitionRx to Acquires Octamer for $725K Cash
  • Benzinga.12/16/2019 13:30

More

Industry

Medical Equipment, Supplies & Distribution
+0.61%
Healthcare Equipment & Supplies
+0.52%

Hot Stocks

Name
Price
%Change

About VNRX

VolitionRx Limited is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The Company has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The Company's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The Company is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The Company's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. It has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.
More

Webull offers VolitionRX Ltd (VNRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.